Exact Mass: 567.3043

Nelfinavir

C32H45N3O4S (567.3131)

Nelfinavir is only found in individuals that have used or taken this drug. It is a potent HIV-1 protease inhibitor. It is used in combination with other antiviral drugs in the treatment of HIV in both adults and children. [PubChem]Nelfinavir inhibits the HIV viral proteinase enzyme which prevents cleavage of the gag-pol polyprotein, resulting in noninfectious, immature viral particles. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AE - Protease inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D000084762 - Viral Protease Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C97366 - HIV Protease Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors

Dracotanoside C

C31H41N3O7 (567.2944)

Tetradehydrolongicaudatine Y

C38H39N4O (567.3124)

Nelfinavir

C32H45N3O4S (567.3131)

J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AE - Protease inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D000084762 - Viral Protease Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C97366 - HIV Protease Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors

3,4,5,6-tetradehydrolongicaudatine Y

[C38H39N4O]+ (567.3124)

cataCXium(R) FPrPh,Dicyclohexyl[9-(3-phenylpropyl)-9-fluorenyl]phosphine tetrafluoroborate

C34H41BF4P (567.2975)

HG-9-91-01

C32H37N7O3 (567.2958)

3-[[(2R)-2-hydroxypropyl]amino]-3-methyl-N-[(3R)-2-oxo-1-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-4,5-dihydro-3H-1-benzazepin-3-yl]butanamide

C32H37N7O3 (567.2958)

Fumigacin

C33H43O8- (567.2958)

3,4,5,6-tetradehydrolongicaudatine Y

C38H39N4O+ (567.3124)

N-[(2R,3S)-2-[[[anilino(oxo)methyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-morpholinyl)propanamide

C30H41N5O6 (567.3057)

3-methoxy-N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-5-[4-oxanyl(oxo)methyl]-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide

C31H41N3O7 (567.2944)

(3S,4aR,8aR)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide

C32H45N3O4S (567.3131)

Lnape 22:6/N-2:0

C29H46NO8P (567.2961)

Lnape 2:0/N-22:6

C29H46NO8P (567.2961)

[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

C29H46NO8P (567.2961)

helvolate

C33H43O8 (567.2958)

The steroid acid anion formed by loss of a proton from the carboxy group of helvolic acid; major microspecies at pH 7.3.

N-tert-butyl-2-[2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide

C32H45N3O4S (567.3131)

LNAPE 24:6

C29H46NO8P (567.2961)

PE 20:5/4:1

C29H46NO8P (567.2961)

PE 22:6/2:0

C29H46NO8P (567.2961)

PE 24:6

C29H46NO8P (567.2961)

ST 21:2;O5;HexNAc

C29H45NO10 (567.3043)

(2z)-1-[(10r)-6-hydroxy-10-(4-{[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)-1,5,9-triazacyclotridec-5-en-1-yl]-3-phenylprop-2-en-1-one

C31H41N3O7 (567.2944)

(2e)-1-[(10r)-6-hydroxy-10-(4-{[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)-1,5,9-triazacyclotridec-5-en-1-yl]-3-phenylprop-2-en-1-one

C31H41N3O7 (567.2944)

(2e)-1-[(8s)-6-hydroxy-8-(4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)-1,5,9-triazacyclotridec-5-en-1-yl]-3-phenylprop-2-en-1-one

C31H41N3O7 (567.2944)

1-(6-hydroxy-8-{4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]phenyl}-1,5,9-triazacyclotridec-5-en-1-yl)-3-phenylprop-2-en-1-one

C31H41N3O7 (567.2944)

(2z)-1-[(8s)-6-hydroxy-8-(4-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}phenyl)-1,5,9-triazacyclotridec-5-en-1-yl]-3-phenylprop-2-en-1-one

C31H41N3O7 (567.2944)